News
🇪🇺 EuropeLatest pharmaceutical news, drug approvals, and EMA regulatory updates
Latest News
Celerion Secures Majority Investment from THL Partners to Expand Clinical Research Services
Clinical research organization Celerion announces majority investment from THL Partners to accelerate growth in drug development services and bioanalytical capabilities.
Veristat Acquires Certara's Regulatory Writing Business to Expand European Market Services
Veristat announces acquisition of Certara's regulatory and medical writing division to enhance clinical trial services for companies entering European markets.
Lung Cancer Therapeutics Market to Hit $142.3 Billion by 2036 as Precision Medicine Drives 11.8% Growth
Global lung cancer therapeutics market projected to grow from $46.8B to $142.3B by 2036, driven by precision medicine and immunotherapy advances.
Drug Delivery Devices Market Poised for Significant Growth Through 2032 Driven by Biologics and Regulatory Support
Drug delivery devices market shows strong growth potential through 2032, fueled by increasing biologics use, technological advances, and supportive regulations.
Polycythemia Vera Market Transformation: 9 Companies Including Protagonist Therapeutics with Rusfertide to Enter by 2036
Nine pharmaceutical companies are advancing polycythemia vera treatments through clinical trials, with Protagonist Therapeutics' rusfertide leading market expansion by 2036.
Ipsen's Ojemda (Tovorafenib) Becomes First Targeted Therapy for Pediatric Brain Tumors in EU
Ipsen's Ojemda receives EU approval as first targeted therapy for pediatric low-grade glioma, addressing critical unmet need in rare brain tumors.
Sanofi's Tzield Receives FDA Approval for Children as Young as 1 Year to Delay Type 1 Diabetes Progression
FDA approves Sanofi's Tzield for children aged 1+ with stage 2 type 1 diabetes, marking the first disease-modifying therapy for this pediatric population.
Pharma 2026 EU: Key Takeaways and Industry Insights
Pharma 2026 EU convened industry leaders to address critical challenges in drug development, regulatory compliance, and market access. Key themes included real-world evidence integration, supply chain resilience, personalized medicine advancement, and investment opportunities in European pharmaceutical innovation.
Pharma 2026 EU: Key Takeaways from Day 1
NovaPharmaNews cannot publish Pharma 2026 EU Day 1 coverage without verified event data, speaker credentials, and company announcements. Complete conference materials are required to maintain editorial standards.
Pharma News: Purdue Sentencing, Supply Chain Woes, ASCO Previews
Purdue Pharma faces sentencing for its role in the opioid crisis, while global pharma supply chains are threatened by conflict. Ascentage Pharma, Jazz Pharmaceuticals, and Incyte announce key data presentations at ASCO 2026.
SLAS Europe 2026: Lab Automation & Screening Innovations
SLAS Europe 2026 will take place May 19-21, 2026, at the Vienna Congress & Convention Center in Vienna, Austria. This conference focuses on laboratory automation, high-throughput screening, and advancements in drug discovery and materials science.
Pharma Partnering EU 2026: Biotech BD&L Trends to Watch
Pharma Partnering EU Summit 2026 in Basel focuses on business development and licensing, featuring one-to-one meetings and discussions on oncology, immunology, and AI.
Pharma Innovation in EU: Previewing Key Trends Beyond Global Pharma Tech
European pharmaceutical innovation is rapidly evolving, driven by Pharma 5.0, digital transformation, and multi-omics. Key events like PHARMAP Congress and NextGen Omics, Tech & Data are shaping the future.
ISCT 2026: Cell & Gene Therapy Manufacturing Innovations in Dublin
The ISCT 2026 Annual Meeting in Dublin will focus on cell and gene therapy advancements, featuring key presentations from Catalent and AGC Biologics. Manufacturing innovations and clinical applications are central themes.
RAPS Euro Convergence 2026: EU MDR & Regulatory Tech
RAPS Euro Convergence 2026, held May 5-8 in Lisbon, focuses on EU MDR/IVDR, combination products, and regulatory tech. Celegence and others will present.
European Research Revolution: Clinical Trial Tech Focus
The European Research Revolution 2026 workshop in Barcelona focuses on technology adoption in European clinical trials. Florence Healthcare hosts the event for pharma and biotech leaders.
Swiss Biotech Day 2026: Previewing Key Biotech Trends
Swiss Biotech Day 2026, held May 4-5 in Basel, Switzerland, will focus on R&D, biomanufacturing, AI, and financing. Over 3,000 professionals are expected to attend.
EU BioPharma Clinical Trials: Key Oncology Data at ASCO & AUA
Key BioPharma clinical trial updates are expected at major conferences in 2026, including ASCO, AUA, and BioPharma Clinical Trials Nexus, focusing on oncology trials.
Reuters Pharma 2024: Key Themes & Speakers in Barcelona
Reuters Events: Pharma 2024 in Barcelona will focus on innovation, market access, and patient centricity, bringing together industry leaders to discuss the future of pharma.
Reuters Pharma 2024: Key Themes & Expert Speakers in Focus
Reuters Events: Pharma 2024 convenes European pharmaceutical leaders to discuss drug development innovation, regulatory strategy, and market access in a rapidly evolving healthcare landscape. The conference features expert panels, networking opportunities, and insights into emerging trends shaping European pharmaceutical markets.